JP2018502838A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502838A5 JP2018502838A5 JP2017530094A JP2017530094A JP2018502838A5 JP 2018502838 A5 JP2018502838 A5 JP 2018502838A5 JP 2017530094 A JP2017530094 A JP 2017530094A JP 2017530094 A JP2017530094 A JP 2017530094A JP 2018502838 A5 JP2018502838 A5 JP 2018502838A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- camkk1
- tissue
- organ
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021032502A JP2021098717A (ja) | 2014-12-01 | 2021-03-02 | 新規の再生治療剤としてのｃａｍｋｋ１ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462086026P | 2014-12-01 | 2014-12-01 | |
| US62/086,026 | 2014-12-01 | ||
| PCT/US2015/063118 WO2016089826A1 (en) | 2014-12-01 | 2015-12-01 | Camkk1 as a novel regenerative therapeutic |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021032502A Division JP2021098717A (ja) | 2014-12-01 | 2021-03-02 | 新規の再生治療剤としてのｃａｍｋｋ１ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502838A JP2018502838A (ja) | 2018-02-01 |
| JP2018502838A5 true JP2018502838A5 (https=) | 2019-01-17 |
| JP6893873B2 JP6893873B2 (ja) | 2021-06-23 |
Family
ID=56092307
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017530094A Active JP6893873B2 (ja) | 2014-12-01 | 2015-12-01 | 新規の再生治療剤としてのｃａｍｋｋ１ |
| JP2021032502A Pending JP2021098717A (ja) | 2014-12-01 | 2021-03-02 | 新規の再生治療剤としてのｃａｍｋｋ１ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021032502A Pending JP2021098717A (ja) | 2014-12-01 | 2021-03-02 | 新規の再生治療剤としてのｃａｍｋｋ１ |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11273208B2 (https=) |
| EP (2) | EP3940068A1 (https=) |
| JP (2) | JP6893873B2 (https=) |
| KR (3) | KR102610068B1 (https=) |
| AU (1) | AU2015355188B2 (https=) |
| CA (1) | CA3007055C (https=) |
| CL (1) | CL2017001390A1 (https=) |
| CR (1) | CR20170301A (https=) |
| IL (2) | IL252612B (https=) |
| RU (1) | RU2017122817A (https=) |
| UA (1) | UA124450C2 (https=) |
| WO (1) | WO2016089826A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA124450C2 (uk) * | 2014-12-01 | 2021-09-22 | Самма Хелт | Спосіб індукції відновлення серця або міокарда або поліпшення функції вказаного серця або міокарда пацієнта |
| EP3781182A4 (en) | 2018-04-18 | 2021-11-17 | Summa Health | COMPOSITIONS AND METHODS OF TREATMENT OF ISCHEMIA AND CARDIOMYOPATHIA |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426206B1 (en) * | 2000-11-13 | 2002-07-30 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| EP1372678A2 (en) | 2001-03-09 | 2004-01-02 | Board of Regents, The University of Texas System | Vectors, compositions and methods for treating a vascular disorder |
| WO2006124013A2 (en) | 2004-04-30 | 2006-11-23 | Five Prime Therapeutics, Inc. | Novel stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof, and method of use |
| US7764995B2 (en) * | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
| WO2006015127A2 (en) * | 2004-07-30 | 2006-02-09 | Mayo Foundation For Medical Education And Research | Treating cardiovascular tissue |
| KR20070085288A (ko) | 2004-09-24 | 2007-08-27 | 안지오블라스트 시스템스 인코퍼레이티드 | 간엽 전구세포의 증식 및/또는 생존성 증강 방법 |
| US20090246179A1 (en) | 2008-02-11 | 2009-10-01 | The Cleveland Clinic Foundation | Method of treating myocardial injury |
| EP2687219A1 (en) | 2012-07-18 | 2014-01-22 | Universität Duisburg-Essen | Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions |
| EP3039124A1 (en) * | 2013-08-29 | 2016-07-06 | Stempeutics Research Private Limited | Stromal cells derived conditioned medium, method of obtaining said conditioned medium compositions, formulations and applications thereof |
| UA124450C2 (uk) * | 2014-12-01 | 2021-09-22 | Самма Хелт | Спосіб індукції відновлення серця або міокарда або поліпшення функції вказаного серця або міокарда пацієнта |
| JP6797803B2 (ja) | 2014-12-31 | 2020-12-09 | セルジーン コーポレイション | ナチュラルキラー細胞を用いて血液障害、固形腫瘍、又は感染性疾患を治療する方法 |
-
2015
- 2015-12-01 UA UAA201706834A patent/UA124450C2/uk unknown
- 2015-12-01 JP JP2017530094A patent/JP6893873B2/ja active Active
- 2015-12-01 CA CA3007055A patent/CA3007055C/en active Active
- 2015-12-01 EP EP21182570.8A patent/EP3940068A1/en active Pending
- 2015-12-01 KR KR1020227037365A patent/KR102610068B1/ko active Active
- 2015-12-01 CR CR20170301A patent/CR20170301A/es unknown
- 2015-12-01 EP EP15864736.2A patent/EP3227441B1/en active Active
- 2015-12-01 KR KR1020177018031A patent/KR102236843B1/ko active Active
- 2015-12-01 WO PCT/US2015/063118 patent/WO2016089826A1/en not_active Ceased
- 2015-12-01 KR KR1020217001921A patent/KR102460983B1/ko active Active
- 2015-12-01 AU AU2015355188A patent/AU2015355188B2/en active Active
- 2015-12-01 RU RU2017122817A patent/RU2017122817A/ru not_active Application Discontinuation
-
2017
- 2017-05-31 CL CL2017001390A patent/CL2017001390A1/es unknown
- 2017-05-31 US US15/610,540 patent/US11273208B2/en active Active
- 2017-06-01 IL IL252612A patent/IL252612B/en unknown
-
2021
- 2021-03-02 JP JP2021032502A patent/JP2021098717A/ja active Pending
- 2021-06-27 IL IL284408A patent/IL284408B/en unknown
-
2022
- 2022-02-08 US US17/667,375 patent/US20220233653A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hu et al. | Islet-1 mesenchymal stem cells-derived exosome-incorporated angiogenin-1 hydrogel for enhanced acute myocardial infarction therapy | |
| Dai et al. | Chronic AMD3100 antagonism of SDF-1α–CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction | |
| Shafei et al. | Mesenchymal stem cell therapy: A promising cell‐based therapy for treatment of myocardial infarction | |
| Takahashi | Role of the SDF-1/CXCR4 system in myocardial infarction | |
| Hong et al. | Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial | |
| Tang et al. | Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector | |
| Xu et al. | Circulating mesenchymal stem cells and their clinical implications | |
| Naderi‐Meshkin et al. | Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy | |
| Li et al. | Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4 | |
| US20150139952A1 (en) | Methods, compositions, cells, and kits for treating ischemic injury | |
| JP2016515533A5 (https=) | ||
| Bagno et al. | Sustained IGF-1 secretion by adipose-derived stem cells improves infarcted heart function | |
| Penke et al. | Molecular determinants of mesenchymal cell activation in fibroproliferative diseases | |
| JP2010540530A5 (https=) | ||
| JP2009545310A5 (https=) | ||
| Zhao et al. | Mesenchymal stem cell biodistribution, migration, and homing in vivo | |
| Wen et al. | SDF-1α and CXCR4 as therapeutic targets in cardiovascular disease | |
| Liang et al. | Hydrogels for the treatment of myocardial infarction: design and therapeutic strategies | |
| Pagano et al. | On the road to regeneration:“tools” and “routes” towards efficient cardiac cell therapy for ischemic cardiomyopathy | |
| Fidelis-de-Oliveira et al. | Soluble factors from multipotent mesenchymal stromal cells have antinecrotic effect on cardiomyocytes in vitro and improve cardiac function in infarcted rat hearts | |
| CN110462023A (zh) | 作为有效成分包括组蛋白去乙酰化酶抑制剂和激活因子的干细胞活性促进用组合物 | |
| Naim et al. | Gene therapy for heart failure: where do we stand? | |
| JP2018502838A5 (https=) | ||
| RU2017122817A (ru) | Camkk1 в качестве нового регенеративного терапевтического средства | |
| Turksen | Adult stem cells and cardiac regeneration |